Kodiak Sciences to Present at Upcoming Investor Conferences

PALO ALTO, Calif., May 30, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at…